RE: Conundrum5 Nov 2024 09:06
The answer to your conundrum WYN is that there are three principle groups of stakeholders in Avacta.
Firstly, there are the company management and the shareholders, this group are fully aware of the potential of the science, they understand the P1 results, they understand how 6103 could revolutionise cancer therapy. The majority of this group have the patience and intellect to understand that at this stage, retention of 100% of the IP is more valuable than a 'quick' deal that might ultimately be seen to be massively undervalued.
Yes there remains questions over mid-term funding but largely they trust the current management regime to explore and deliver from the several funding options open to them
The second group of stakeholders are BP, they are aware of AVCT from the data already presented this year at AACR, ESMO & EORTC. CC explained that they are inherently slow & conservative and require comprehensive data. We have to assume from the resumes of the SB, CC, SC, MM, PF, DDH and the SAB that our current management team has broad experience and significant links to both BP and the regulatory authorities.
We don't know what BP are thinking or how interested they are/aren't but we have to believe that it would be inconceivable that something so potentially revolutionary isn't on their radar. BP have to decide when they have seen enough and when is the right time to stick or twist, this is their gamble, go early or wait and miss out.
Thirdly, there is 'the market'. We know the AIM market doesn't understand the science, you only have to reference the ill informed nonsense from Paul Cuddon to confirm that.
All the market can see is a small cap pharma Co with no revenues, no profit, a quarterly debt obligation, a TX division it wants rid of, no obvious plan for mid term funding with no obvious timeline for any of its wonderful science to reach commerciality. From this perspective you can understand why the market values the Co at 50p but is that an ill informed conclusion?
The $64,000 question for all stakeholders is, where is this headed next? All three groups have to answer this question and at least one of them will be making a huge mistake.